Human Formulations

Mecobalamine 1500mcg + ALA 100mg + inositol 100mg + Folic Acid 1.5mg + Chromium Polynicotinate 200mcg + Selenium Dioxide 55mcg + Benfotiamine 150mg

Mecobalamine 1500mcg + ALA 100mg + inositol 100mg + Folic Acid 1.5mg + Chromium Polynicotinate 200mcg + Selenium Dioxide 55mcg + Benfotiamine 150mg is a capsule formulated with Mecobalamine 1500mcg + ALA 100mg + inositol 100mg + Folic Acid 1.5mg + Chromiu

CapsulesNon-Beta-Lactam Capsules Single Ingredient Capsule
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Capsules, Non-Beta-Lactam Capsules
Dosage Form
Capsule
Product Type
Single Ingredient

Available strengths

Mecobalamine 1500mcg + ALA 100mg + inositol 100mg + Folic Acid 1.5mg + Chromium Polynicotinate 200mcg + Selenium Dioxide 55mcg + Benfotiamine 150mg

Description

Mecobalamine 1500mcg + ALA 100mg + inositol 100mg + Folic Acid 1.5mg + Chromium Polynicotinate 200mcg + Selenium Dioxide 55mcg + Benfotiamine 150mg is a capsule formulated with Mecobalamine 1500mcg + ALA 100mg + inositol 100mg + Folic Acid 1.5mg + Chromium Polynicotinate 200mcg + Selenium Dioxide 55mcg + Benfotiamine 150mg. The listed active ingredient profile is Mecobalamine; ALA; inositol; Folic Acid; Chromium Polynicotinate; Selenium Dioxide; Benfotiamine, placing the product in the neuropathic pain / neuro-nutritional category. The formulation contains neuropathic-pain and/or neuro-nutritional components used in selected nerve-related conditions under clinician guidance. The source identifies the dosage form as capsule with not specified presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured